Award
National Institute of Allergy and Infectious Diseases 5R01AI136041-13
Eicosanoid Networks in Aspirin Hypersensitivity
Recipient
Brigham and Women's Hospital, Boston, MA, United States
Award Amount
$656,461.00
Ceiling
$656,461.00
Awarded
December 03, 2025
Identifier
5R01AI136041-13
Research project funded by NIAID to study aspirin hypersensitivity and develop new therapies for aspirin exacerbated respiratory disease (AERD).
Description
This proposal focuses on the underlying causes of aspirin exacerbated respiratory disease (AERD), a severe form of asthma and sinus disease. The results of these studies will aid in understanding the underlying causes of AERD and should point the way to new therapies.